Clinical Considerations of Sugammadex
Date
2017
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This purpose of this research was to assess and improve the level of understanding of the newly FDA approved drug Sugammadex within the Adventist University Student Registered nurse anesthetist (SRNA) population regarding indications for use, dosing, pharmacological profile, and side effects of the new drug. Our goal was to increase knowledge of the students so that they would feel more comfortable using the new reversal agent if the opportunity presented in the clinical setting or future practice. An extensive literature review was performed to create a thorough teaching module for the SRNA students. A pre-test was administered prior to the teaching module being presented. A teaching module on Sugammadex was presented to the SRNA students and was followed by a post-test. The pre-test and the post-test were given to evaluate whether the teaching on Sugammadex had been effective. Statistical analysis using a paired t-test showed that average scores increased significantly between pre-test and post-test administrations. The mean pre-test score was 5.9 with a standard deviation of 2.30718. In comparison, the mean post-test score was 9.275 with a standard deviation of 1.37724. Therefore, the average scores increased significantly between pre-test and post-test administrations. The Sugammadex teaching module was an effective tool that can be used to educate SRNAs and possibly CRNAs in the future.
Description
item.page.type
Image
Other
Other